Skip to main content
Pathway Health Corp. logo

Pathway Health Corp. — Investor Relations & Filings

ISIN · CA70324L1058 LEI · 984500AB5C0A5E0D4392 TSXV Human health and social work activities
Filings indexed 203 across all filing types
Latest filing 2021-02-17 Declaration of Voting R…
Country CA Canada
Listing TSXV

About Pathway Health Corp.

https://pathwayhealth.ca/

Pathway Health Corp. is a healthcare organization specializing in the provision of out-of-hospital pain management services. The company operates a network of community-based clinics that deliver multi-disciplinary therapies and medically managed intensive outpatient programs. Its primary focus is assisting patients suffering from chronic pain, with an expanded scope now addressing mental illness following a corporate combination with other health and wellness firms. Beyond clinical operations, Pathway Health also functions as a professional management and consulting organization, offering strategic technology implementation and education solutions across the healthcare continuum. This dual focus positions the company as a comprehensive provider of specialized health services.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date (amended) - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a brief notice addressed to various securities commissions regarding details of an upcoming Annual and Special Meeting of Shareholders for Colson Capital Corp. It includes meeting date, record dates for notice and voting, and other procedural details. The document is short (1182 characters) and does not contain any financial data, analysis, or detailed report content. It is an announcement related to shareholder meeting logistics rather than the meeting materials or results themselves. Therefore, it fits best as a Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly a Regulatory Filing (RNS). However, since it specifically provides information about the meeting and voting rights, the most appropriate classification is DVA.
2021-02-17 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2021-02-12 English
News release - English.pdf
Regulatory Filings
2021-02-03 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Material Change Report Form 51-102F3' and details a significant corporate transaction involving a reverse takeover and qualifying transaction under TSX Venture Exchange policies. It includes a detailed description of the transaction terms, conditions precedent, financing offering, and related corporate actions. The document is a regulatory filing reporting a material change event rather than a full financial report or earnings release. It is not an announcement of voting results, nor a management or board change notice. The form number 51-102F3 corresponds to a material change report under Canadian securities regulations, which is a type of regulatory filing. Therefore, the document fits best under the category of Regulatory Filings (RNS). The document length (15,000 characters) and detailed content confirm it is not a brief announcement or a report publication notice but a substantive regulatory disclosure.
2020-12-03 English
Interim financial statements/report – English.pdf
Regulatory Filings
2020-11-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2020-11-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.